Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Palumbo, Antonio, Bringhen, Sara, Ludwig, Heinz, Dimopoulos, Meletios A., Bladé, Joan, Mateos, Maria V., Rosiñol, Laura, Boccadoro, Mario, Cavo, Michele, Lokhorst, Henk, Zweegman, Sonja, Terpos, Evangelos, Davies, Faith, Driessen, Christoph, Gimsing, Peter, Gramatzki, Martin, Hàjek, Roman, Johnsen, Hans E., Leal Da Costa, Fernando, Sezer, Orhan, Spencer, Andrew, Beksac, Meral, Morgan, Gareth, Einsele, Hermann, San Miguel, Jesus F., Sonneveld, Pieter
Published in Blood (27.10.2011)
Published in Blood (27.10.2011)
Get full text
Journal Article
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma
Plesner, Torben, Arkenau, Hendrik-Tobias, Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Palumbo, Antonio, Lisby, Steen, Basse, Linda, Wang, Jianping, Sasser, A. Kate, Guckert, Mary E., de Boer, Carla, Khokhar, Nushmia Z., Yeh, Howard, Clemens, Pamela L., Ahmadi, Tahamtan, Lokhorst, Henk M., Richardson, Paul G.
Published in Blood (06.10.2016)
Published in Blood (06.10.2016)
Get full text
Journal Article
Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma
Johnsen, Hans E., Bøgsted, Martin, Klausen, Tobias W., Gimsing, Peter, Schmitz, Alexander, Kjærsgaard, Erik, Damgaard, Tina, Voss, Pia, Knudsen, Lene M., Mylin, Anne K., Nielsen, Johan Lanng, Björkstrand, Bo, Gruber, Astrid, Lenhoff, Stig, Remes, Kari, Dahl, Inger Marie, Fogd, Kirsten, Dybkær, Karen
Published in Cytometry. Part B, Clinical cytometry (01.09.2010)
Published in Cytometry. Part B, Clinical cytometry (01.09.2010)
Get full text
Journal Article
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
Fayers, Peter M., Palumbo, Antonio, Hulin, Cyrille, Waage, Anders, Wijermans, Pierre, Beksaç, Meral, Bringhen, Sara, Mary, Jean-Yves, Gimsing, Peter, Termorshuizen, Fabian, Haznedar, Rauf, Caravita, Tommaso, Moreau, Philippe, Turesson, Ingemar, Musto, Pellegrino, Benboubker, Lotfi, Schaafsma, Martijn, Sonneveld, Pieter, Facon, Thierry
Published in Blood (04.08.2011)
Published in Blood (04.08.2011)
Get full text
Journal Article
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
Waage, Anders, Gimsing, Peter, Fayers, Peter, Abildgaard, Niels, Ahlberg, Lucia, Björkstrand, Bo, Carlson, Kristina, Dahl, Inger Marie, Forsberg, Karin, Gulbrandsen, Nina, Haukås, Einar, Hjertner, Øyvind, Hjorth, Martin, Karlsson, Torbjörn, Knudsen, Lene Meldgaard, Nielsen, Johan Lanng, Linder, Olle, Mellqvist, Ulf-Henrik, Nesthus, Ingerid, Rolke, Jürgen, Strandberg, Maria, Sørbø, Jon Hjalmar, Wisløff, Finn, Juliusson, Gunnar, Turesson, Ingemar
Published in Blood (02.09.2010)
Published in Blood (02.09.2010)
Get full text
Journal Article
Cereblon Is Downregulated By Promoter Nucleosome Occupancy in Acquired IMiD Resistance: The Potential of IMiD Resensitization By Epigenetic Therapy
Dimopoulos, Konstantinos, Gimsing, Peter, Liang, Gangning, Grønbæk, Kirsten, Helbo Søgaard, Alexandra, Lakshminarasinham, Ranjani
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Mellqvist, Ulf-Henrik, Gimsing, Peter, Hjertner, Oyvind, Lenhoff, Stig, Laane, Edward, Remes, Kari, Steingrimsdottir, Hlif, Abildgaard, Niels, Ahlberg, Lucia, Blimark, Cecilie, Dahl, Inger Marie, Forsberg, Karin, Gedde-Dahl, Tobias, Gregersen, Henrik, Gruber, Astrid, Guldbrandsen, Nina, Haukås, Einar, Carlson, Kristina, Kvam, Ann Kristin, Nahi, Hareth, Lindås, Roald, Andersen, Niels Frost, Turesson, Ingemar, Waage, Anders, Westin, Jan
Published in Blood (06.06.2013)
Published in Blood (06.06.2013)
Get full text
Journal Article
Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry
Redder, Louise, Klausen, Tobias Wirenfeldt, Vangsted, Annette Juul, Gregersen, Henrik, Andersen, Niels Frost, Pedersen, Robert Schou, Plesner, Torben, Frederiksen, Mikael, Frølund, Ulf Christian, Helleberg, Carsten, Nielsen, Lene Kongsgaard, Salomo, Morten, Gimsing, Peter, Frederiksen, Henrik, Abildgaard, Niels
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02/HO95 Study
Cavo, Michele, Gay, Francesca, Beksac, Meral, Dimopoulos, Meletios A, Pantani, Lucia, Petrucci, Maria Teresa, Dozza, Luca, Van Der Holt, Bronno, Zweegman, Sonja, Zamagni, Elena, Palumbo, Giuseppe A., Patriarca, Francesca, Galli, Monica, Maisnar, Vladimir, Hansson, Markus, Belotti, Angelo, Pour, Ludek, Ypma, Paula F, Grasso, Mariella, Croockewit, Sandra, Offidani, Massimo, Zambello, Renato, Liberati, Anna Marina, Andersen, Niels Frost, Broyl, Annemiek, Troia, Rossella, Musto, Pellegrino, Ludwig, Heinz, Morelli, Anna Maria, Hajek, Roman, Driessen, Christoph, Waage, Anders, Gimsing, Peter, Mellqvist, Ulf-Henrik, Zander, Thilo, Boccadoro, Mario, Sonneveld, Pieter
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels Are Associated with Multiple Myeloma Bone Disease
Westhrin, Marita, Moen, Siv Helen, Holien, Toril, Olsen, Oddrun Elise, Mylin, Anne Kærsgaard, Gimsing, Peter, Turesson, Ingemar, Waage, Anders, Standal, Therese
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group
Stege, Claudia A.M., van der Holt, Bronno, Mellqvist, Ulf-Henrik, Levin, Mark-David, Salomo, Morten, Abildgaard, Niels, Bos, Gerard, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette, Deenik, Wendy, Gruber, Astrid, Coenen, Jules L.L.M., Plesner, Torben, Klein, Saskia, Tanis, Bea, Szatkowski, Damian L., Brouwer, Rolf, Westerman, Matthijs, Leijs, Maria Berhardina, Sinnige, Harm, Haukaas, Einar, van der Hem, Klaas, Durian, Marc, Mattijssen, Vera, Gimsing, Peter, Van De Donk, Niels WCJ, Stevens-Kroef, Marian, Sonneveld, Pieter, Waage, Anders, Zweegman, Sonja
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
A Phase I/II, Dose-Escalation Study of Daratumumab, A CD38 Mab in Patients with Multiple Myeloma – Preliminary Safety Data
Gimsing, Peter, Plesner, Torben, Nahi, Hareth, Lokhorst, Henk, Valentin, Marie-Louise, Lisby, Steen, Richardson, Paul G.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Updated Results of a Phase 1/2 Study (GEN503)
Plesner, Torben, Arkenau, Hendrik-Tobias, Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Palumbo, Antonio, Lisby, Steen, Basse, Linda, Wang, Jianping, Sasser, A Kate, Guckert, Mary E, Yeh, Howard, Ahmadi, Tahamtan, Lokhorst, Henk M., Richardson, Paul G.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex
Lund, Johan, Karstorp, Sigrid, Alici, Evren, Gruber, Astrid, Lauri, Birgitta, Blimark, Cecilie, Swedin, Agneta, Hansson, Markus, Forsberg, Karin, Ahlberg, Lucia, Conny, Carlsson, Waage, Anders, Gimsing, Peter, Vangsted, Annette Juul, Frølund, Ulf Christian, Hardling, Mats, Mellqvist, Ulf-Henrik, Nahi, Hareth
Published in BLOOD (03.12.2015)
Published in BLOOD (03.12.2015)
Get full text
Journal Article
Conference Proceeding
Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma - Data From a Dose-Escalation Phase I/II Study
Plesner, Torben, Lokhorst, Henk, Gimsing, Peter, Nahi, Hareth, Lisby, Steen, Richardson, Paul G.
Published in BLOOD (16.11.2012)
Published in BLOOD (16.11.2012)
Get full text
Journal Article
Conference Proceeding
Preliminary Safety and Efficacy Data Of Daratumumab In Combination With Lenalidomide and Dexamethasone In Relapsed Or Refractory Multiple Myeloma
Plesner, Torben, Arkenau, Tobias, Lokhorst, Henk, Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Cakana, Andrew, Brun, Nikolai Constantin, Basse, Linda, Palumbo, Antonio, Richardson, Paul G.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
Plesner, Torben, Arkenau, Hendrik-Tobias, Lokhorst, Henk M., Gimsing, Peter, Krejcik, Jakub, Lemech, Charlotte, Minnema, Monique C., Lassen, Ulrik, Laubach, Jacob P., Ahmadi, Tahamtan, Yeh, Howard, Guckert, Mary E, Feng, Huaibao, Brun, Nikolai Constantin, Lisby, Steen, Basse, Linda, Palumbo, Antonio, Richardson, Paul G.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma : A population-based study
LENHOFF, S, HJORTH, M, DAHL, I.-M, GIMSING, P, HIPPE, E, JOHNSEN, H, LAMVIK, J, LÖFVENBERG, E, NESTHUS, I, RÖDJER, S, HOLMBERG, E, TURESSON, I, WESTIN, J, NIELSEN, J. L, WISLÖFF, F, BRINCH, L, CARLSON, K, CARLSSON, M
Published in Blood (2000)
Get full text
Published in Blood (2000)
Journal Article
Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537)
Moreau, Philippe, Masszi, Tamás, Grzasko, Norbert, Bahlis, Nizar J, Hansson, Markus, Pour, Ludek, Sandhu, Irwindeep, Ganly, Peter, Baker, Bartrum W, Jackson, Sharon, Stoppa, Anne-Marie, Simpson, David R, Gimsing, Peter, Palumbo, Antonio, Garderet, Laurent, Cavo, Michele, Kumar, Shaji K., Touzeau, Cyrille, Buadi, Francis, Laubach, Jacob P., Lin, Jianchang, Berg, Deborah, DiBacco, Alessandra, Hui, Ai-Min, Richardson, Paul G.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
A Phase II Study of Bortezomib-Dexametason Followed by High-Dose Melphalan Combined with Bortezomib in Patients Relapsing After High-Dose Melphalan with Autologous Stem Cell Support
Gimsing, Peter, Hjertner, Oyvind, Abildgaard, Niels, Andersen, Niels Frost, Dahl, Tobias Gedde, Gregersen, Henrik, Mellqvist, Ulf-Henrik, Linder, Olle, Lindas, Roald, Clausen, Niels-Aage Tøfner, Lenhoff, Stig
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article